Amarin Corp Plcuk (AMRN) Net Cash Flow (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Net Cash Flow of -$3.6 million for Q1 2026, down 137.58% YoY from $9.6 million in Q1 2025, and down 130.59% sequentially from $11.8 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Net Cash Flow (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Net Cash Flow across 17 years of filings, most recently posting -$3.6 million for Q1 2026.

  • In Q1 2026, Net Cash Flow fell 137.58% year-over-year to -$3.6 million; the TTM figure through Mar 2026 stood at $11.4 million (up 112.09% YoY), while the FY2025 annual figure was $13.5 million, up 117.24% from the prior year.
  • Net Cash Flow fell to -$3.6 million in Q1 2026, from $11.8 million in the prior quarter.
  • Over the last five years, Net Cash Flow for AMRN reached as high as $41.6 million in Q2 2023 and fell as low as -$71.6 million in Q4 2023.
  • The 5-year median for Net Cash Flow is -$303000.0 (2022), against an average of -$5.4 million.
  • Annual changes were most pronounced in 2023 — Net Cash Flow tumbled 8564.69% — and 2025, when it soared 1331.97%.
  • A 5-year view of Net Cash Flow shows it stood at -$26.2 million in 2022, then tumbled by 172.83% to -$71.6 million in 2023, then surged by 49.51% to -$36.1 million in 2024, then surged by 132.54% to $11.8 million in 2025, then plunged by 130.59% to -$3.6 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods registered -$3.6 million, $11.8 million, and -$25.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -2.05 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 2.00 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 4.17 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -1.53 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -9.27 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 2.91 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 75.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 544.00 Mn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn -3.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.60 Mn
Mar 31, 2026 -3.60 Mn
Dec 31, 2025 11.76 Mn
Dec 31, 2025 11.76 Mn
Sep 30, 2025 -25.07 Mn
Sep 30, 2025 -25.07 Mn
Jun 30, 2025 28.35 Mn
Jun 30, 2025 28.35 Mn
Mar 31, 2025 -1.51 Mn
Mar 31, 2025 -1.51 Mn
Dec 31, 2024 -36.13 Mn
Dec 31, 2024 -36.13 Mn
Sep 30, 2024 -58.98 Mn
Sep 30, 2024 -58.98 Mn
Jun 30, 2024 1.98 Mn
Jun 30, 2024 1.98 Mn
Mar 31, 2024 14.69 Mn
Mar 31, 2024 14.69 Mn
Dec 31, 2023 -71.56 Mn
Dec 31, 2023 -71.56 Mn